Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by TheLandedEagleson Aug 17, 2022 1:23pm
244 Views
Post# 34902572

RE:UPDATE From Mr. Fia for all long term investors....

RE:UPDATE From Mr. Fia for all long term investors....What I found interesting in video update is that they (FIA), also stated that they are in general discussion and receptive to a possible JV or buyout posibility with related parties in this space...quite possible once FDA approval is secured...they may... announce this at same time, or shortly thereafter approval. Wouldnt surprise me, if bigger player takes over MFG and distribution of this new saliva test...will definately require  more capital anyhow, if they go full speed with production....that will cause more dilution of course and therefore, a sale may be more adventagous for all shareholders in my opinion... Fia, is probably looking at this as his exist stratagy....just my thoughts...
<< Previous
Bullboard Posts
Next >>